Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy.

Immunological parameters following chemoimmunotherapy combination were studied in 31 patients with metastatic malignant melanoma. They received Cisplatin (100 mg/m2) on day 1 and 28, recombinant IL-2 (rIL-2; Eurocetus) in continuous infusion from day 3 to 6, 17 to 21, 31 to 34 and 45 to 49. Interfer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Soubrane, C, Mouawad, R, Ichen, M, Suissa, J, Borel, C, Vuillemin, E, Benhammouda, A, Bizzari, J P, Weil, M, Khayat, D
Formato: Artigo
Idioma:Inglês
Publicado em: 1994
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1534932/
https://ncbi.nlm.nih.gov/pubmed/8306497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados